Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics

References

• Adams G. E., Clarke E. D., Flockhart I. R., Jacobs R. S., Sehmi D. S., Stratford I. J., Wardman P., Watts M. E., Parrick J., Wallace R. G., Smithen C. E. Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. International Journal of Radiation Biology 1979; 35: 133–150
   Web of Science ®Google Scholar
• Arcangeli G., Barolas A., Mauro F., Nerri C., Sparo M., Tabocchini A. Multiple daily fractionation radiotherapy in association with hyperthermia and/or misonidazole: experimental and clinical results. Cancer 1980; 45: 2707–2711
   PubMed Web of Science ®Google Scholar
• Coleman C. N. Hypoxic cell radiosensitizers: expectations and progress in drug development. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 323–329
   PubMed Web of Science ®Google Scholar
• Denekemp J. Tumor regression as a guide to prognosis: a study with experimental animals. British Journal of Radiology 1977; 50: 271–279
   PubMed Web of Science ®Google Scholar
• Dewey W. C., Hopewood L. E., Sapreto S. A., Gerweck L. E. Cellular responses to combination of hyperthermia and radiation. Radiobiology 1977; 123: 463–474
   Google Scholar
• Goldfeder A., Brown D. M., Berger A. Enhancement of radioresponse of a mouse mammary carcinoma to combine treatments with hyperthermia and radiosensitizer misonidazole. Cancer Research 1979; 39: 2966–2970
   PubMed Web of Science ®Google Scholar
• Gray L. H., Gorger A. O., Ebert M., Hornsey S., Scott O. C. A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherpy. British Journal of Radiology 1953; 26: 638–648
   PubMed Web of Science ®Google Scholar
• Hall E. J., Roizin-Towle L. Hypoxic sensitizers: radiobiological studies at the cellular level. Radiology 1975; 117: 453–457
   PubMed Web of Science ®Google Scholar
• Heimbooke D. C., Sartorelli A. C. Biochemistry of misonidazole reduction by NADPH-cytochrome (P-450) reductase. Molecular Pharmacology 1985; 29: 168–172
   Web of Science ®Google Scholar
• Hofer K. G., Hofer M. G., Ieracitano J., McLanghlin W. H. Radiosensitization of hypoxic tumor cells by simultaneous administration of hyperthermia and nitroimidazoles. Radiation Research 1977; 70: 362–377
   PubMed Web of Science ®Google Scholar
• Hofer K. G., Mackinnon A. R., Schubert A. L., Lehr J. E., Grimmett E. V. Radiosensitization of tumors and normal tissues by combined treatment with misonidazole and heat. Radiology 1981; 141: 801–809
   PubMed Web of Science ®Google Scholar
• Honess D. J., Workman P., Morgan J. E., Bleehen N. M. Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anesthetized mouse. British Journal of Cancer 1980; 41: 529–540
   PubMed Web of Science ®Google Scholar
• Kagiya T., Wade T., Nishimoto S. C. Molecular mechanism of radiosensitization by nitro compounds. Modification of Radiosensitivity in Cancer Treatment, T. Sugahara. Academia Press, Japan 1984; 85–106
   Google Scholar
• Li G. C., Evans R. G., Hahn G. M. Modification and inhibition of potentially lethal X-ray damage by hyperthermia. Radiation Research 1976; 67: 491–501
   PubMed Web of Science ®Google Scholar
• Narayana V. L., Lee W. W. Development of radiosensitizers: a medicinal chemistry perspective. Advances in Pharmacology and Chemotherapy 1982; 19: 155–204
   PubMedGoogle Scholar
• Overgaard J. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. British Journal of Cancer 1980; 41: 10–21
   PubMed Web of Science ®Google Scholar
• Overgaard J. The current and potential role of hyperthermia in radiotherapy. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 535–549
   PubMed Web of Science ®Google Scholar
• Perez-Reyes E., Kalyanaraman B., Mason R. P. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes. Molecular Pharmacology 1980; 17: 239–244
   PubMed Web of Science ®Google Scholar
• Rajaratnam S., Adams G. E., Stratford I. J., Clarke C. Enhancement of the cytotoxicity of radiosensitizers by modest hyperthermia: the electron-affinity relationship. British Journal of Cancer 1982; 46: 912–917
   PubMed Web of Science ®Google Scholar
• Sarareto S. A., Raaphorst G. P., Dewey W. C. Cell killing and the sequencing of hyperthermia and radiation. International Journal of Radiation Oncology, Biology and Physics 1979; 5: 343–348
   PubMed Web of Science ®Google Scholar
• Sheldon P. W., Hill S. A. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumor in mice. British Journal of Cancer 1977; 35: 795–808
   PubMed Web of Science ®Google Scholar
• Song C. W. Effects of local hyperthermia on blood flow and microenvironment: a review. Cancer Research 1984; 44(Supplement)4721s–4730s
   Google Scholar
• Song C. W., Rhee J. G., Levitt S. H. Effect of hyperthermia on hypoxic cell fraction in tumor. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 851–856
   PubMed Web of Science ®Google Scholar
• Stratford I. J., Adams G. E. Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07–0582, on mammalian cell in vitro. British Journal of Cancer 1977; 35: 307–313
   PubMed Web of Science ®Google Scholar
• Urano M., Gerweck L. E., Epstein R., Gunningham M., Suit H. D. Response of a spontaneous murine tumor to hyperthermia: factors which modify the thermal respons in vitro. Radiation Research 1980; 83: 312–322
   PubMed Web of Science ®Google Scholar
• Urano J., Kahn J. The change in hypoxic and chronically hypoxic cell fraction in murine tumor treated with hyperthermia. Radiation Research 1983; 96: 549–559
   PubMed Web of Science ®Google Scholar
• Uano M., Kenton L., Kahn J. The effect of hyperthermia on the early- and late-appearing mouse foot reactions and on the radiation carcinogensis. I. Effect on the early-and late-appearing reactions. International Journal of Radiation Oncology, Biology and Physics 1988; 15: 159–166
   PubMed Web of Science ®Google Scholar
• Urtasun R., Band P., Chapman D. J., Feldstein M. L., Mielke B., Fryer C. Radiation and high-dose metronidazole in supratentorial glioblastomas. New England Journal of Medicine 1976; 294: 1364–1367
   PubMed Web of Science ®Google Scholar
• Urtasun R., Chapman J. D., Band P., Rabin H. R., Fryer C. G., Sturmwind J. Phase I study of high-dose metronidazole: a specific in vivo, in vitro radiosensitizer of hypoxic cells. Radiology 1975; 117: 129–133
   PubMed Web of Science ®Google Scholar
• Varghese A. J., Galyas S., Mohindra J. K. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro an in vivo. Cancer Research 1976; 36: 3761–3765
   PubMed Web of Science ®Google Scholar
• Walton M. I., Bleehen N. M., Workman P. Effects of localized tumor hyperthermia on pimonidazole (Ro 03–8799) pharmacokinetics in mice. British Journal of Cancer 1989a; 59: 667–673
   PubMed Web of Science ®Google Scholar
• Walton M. I., Bleehen N. M., Workman P. Stimulation of localized tumor hyper-thermia of reductive bioactivation of 2-nitroimidazole benznidazole in mice. Cancer Research 1989b; 49: 2351–2355
   PubMed Web of Science ®Google Scholar
• Wasserman T. H., Stetz J., Phillips T. L. Clinical trials of misonidazole in the United States. Cancer Clinical Trials 1981; 4: 7–16
   PubMedGoogle Scholar
• Wondergem J., Haveman J., van der Schueren E., van der Hoeren H., Beur K. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells. International Journal of Radiation Oncology, Biology and Physics 1986; 8: 1323–1331
   Google Scholar
• Wong K-H., Wallen C. A., Wheeler K. T. Biodistribution on misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors. International Journal of Radiation Oncology, Biology and Physics 1989; 17: 135–143
   PubMed Web of Science ®Google Scholar